Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Economic impact of antimicrobial resistance.

Literature DB >> 11294725

Economic impact of antimicrobial resistance.

Abstract

One reason antimicrobial-drug resistance is of concern is its economic impact on physicians, patients, health-care administrators, pharmaceutical producers, and the public. Measurement of cost and economic impact of programs to minimize antimicrobial-drug resistance is imprecise and incomplete. Studies to describe and evaluate the problem will have to employ new methods and be of large scale to produce information that is broadly applicable.

Entities: Species

Mesh：

Year: 2001 PMID： 11294725 PMCID： PMC2631707 DOI： 10.3201/eid0702.010228

Source DB: PubMed Journal: Emerg Infect Dis ISSN： 1080-6040 Impact factor: 6.883

42 in total

1. Cost considerations in the evaluation of new therapies for gram-positive bacteria.

Authors: D Nathwani; M Malek
Journal: Int J Antimicrob Agents Date: 1999-10 Impact factor: 5.283

Review 2. Epidemiology of drug resistance: implications for a post-antimicrobial era.

Authors: M L Cohen
Journal: Science Date: 1992-08-21 Impact factor: 47.728

Review 3. Cost and benefit of perioperative antimicrobial prophylaxis: methods for economic analysis.

Authors: J E McGowan
Journal: Rev Infect Dis Date: 1991 Sep-Oct

Review 4. Superbugs: should antimicrobial resistance be included as a cost in economic evaluation?

Authors: J Coast; R D Smith; M R Millar
Journal: Health Econ Date: 1996 May-Jun Impact factor: 3.046

5. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals.

Authors: D M Shlaes; D N Gerding; J F John; W A Craig; D L Bornstein; R A Duncan; M R Eckman; W E Farrer; W H Greene; V Lorian; S Levy; J E McGowan; S M Paul; J Ruskin; F C Tenover; C Watanakunakorn
Journal: Infect Control Hosp Epidemiol Date: 1997-04 Impact factor: 3.254

6. Evaluation of Acinetobacter baumannii infection and colonization, and antimicrobial treatment patterns in an urban teaching hospital.

Authors: C M Weingarten; M J Rybak; B E Jahns; J G Stevenson; W J Brown; D P Levine
Journal: Pharmacotherapy Date: 1999-09 Impact factor: 4.705

Review 7. Economic evaluations of antibiotic use and resistance--a perspective: report of Task Force 6.

Authors: R H Liss; F R Batchelor
Journal: Rev Infect Dis Date: 1987 May-Jun

8. Bug/drug resistance. Sometimes less is more.

Authors: C E Phelps
Journal: Med Care Date: 1989-02 Impact factor: 2.983

Review 9. Do intensive hospital antibiotic control programs prevent the spread of antibiotic resistance?

Authors: J E McGowan
Journal: Infect Control Hosp Epidemiol Date: 1994-07 Impact factor: 3.254

10. Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms.

Authors: C González; M Rubio; J Romero-Vivas; M González; J J Picazo
Journal: Clin Infect Dis Date: 1999-11 Impact factor: 9.079

34 in total

1. Experimental prediction of the natural evolution of antibiotic resistance.

Authors: Miriam Barlow; Barry G Hall
Journal: Genetics Date: 2003-04 Impact factor: 4.562

Review 2. Rapid detection of antimicrobial-resistant organism carriage: an unmet clinical need.

Authors: Daniel J Diekema; Kirsty J Dodgson; Bryndis Sigurdardottir; Michael A Pfaller
Journal: J Clin Microbiol Date: 2004-07 Impact factor: 5.948

3. Evolution of a single gene highlights the complexity underlying molecular descriptions of fitness.

Authors: Matthew I Peña; Elizabeth Van Itallie; Matthew R Bennett; Yousif Shamoo
Journal: Chaos Date: 2010-06 Impact factor: 3.642

4. Adequacy of an evidence-based treatment guideline for complicated urinary tract infections in the Netherlands and the effectiveness of guideline adherence.

Authors: V Spoorenberg; J M Prins; E E Stobberingh; M E J L Hulscher; S E Geerlings
Journal: Eur J Clin Microbiol Infect Dis Date: 2013-07-04 Impact factor: 3.267

5. Trends in antibiotic prescribing for adults in the United States--1995 to 2002.

Authors: Christianne L Roumie; Natasha B Halasa; Carlos G Grijalva; Kathryn M Edwards; Yuwei Zhu; Robert S Dittus; Marie R Griffin
Journal: J Gen Intern Med Date: 2005-08 Impact factor: 5.128

6. Practical implementation of a multiplex PCR for acute respiratory tract infections in children.

Authors: Paul Gruteke; Afina S Glas; Mirjam Dierdorp; Willem B Vreede; Jan-Willem Pilon; Sylvia M Bruisten
Journal: J Clin Microbiol Date: 2004-12 Impact factor: 5.948

7. Socioeconomic determinants of outpatient antibiotic use in Europe.

Authors: Giuliano Masiero; Massimo Filippini; Matus Ferech; Herman Goossens
Journal: Int J Public Health Date: 2010-07-07 Impact factor: 3.380

8. Clinicians' knowledge, attitudes, and practices regarding infections with multidrug-resistant gram-negative bacilli in intensive care units.

Authors: Juyan Julia Zhou; Sameer J Patel; Haomiao Jia; Scott A Weisenberg; E Yoko Furuya; Christine J Kubin; Luis Alba; Kyu Rhee; Lisa Saiman
Journal: Infect Control Hosp Epidemiol Date: 2013-01-24 Impact factor: 3.254

9. KiDoQ: using docking based energy scores to develop ligand based model for predicting antibacterials.

Authors: Aarti Garg; Rupinder Tewari; Gajendra P S Raghava
Journal: BMC Bioinformatics Date: 2010-03-11 Impact factor: 3.169

10. Safety and efficacy of polymyxin B in multidrug resistant Gram-negative severe sepsis and septic shock.

Authors: Suresh Ramasubban; Ayanava Majumdar; Purnendu Sekhar Das
Journal: Indian J Crit Care Med Date: 2008-10